WO1994006492A1 - Accumulator for implantable pump - Google Patents

Accumulator for implantable pump Download PDF

Info

Publication number
WO1994006492A1
WO1994006492A1 PCT/US1993/006775 US9306775W WO9406492A1 WO 1994006492 A1 WO1994006492 A1 WO 1994006492A1 US 9306775 W US9306775 W US 9306775W WO 9406492 A1 WO9406492 A1 WO 9406492A1
Authority
WO
WIPO (PCT)
Prior art keywords
accumulator
diaphragm
chamber
pressure
spring
Prior art date
Application number
PCT/US1993/006775
Other languages
French (fr)
Inventor
Paul F. Burke
Samir F. Idriss
Original Assignee
Infusaid, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infusaid, Inc. filed Critical Infusaid, Inc.
Priority to DE69308578T priority Critical patent/DE69308578T2/en
Priority to DE9390324U priority patent/DE9390324U1/en
Priority to AU46840/93A priority patent/AU674332B2/en
Priority to EP93917277A priority patent/EP0660728B1/en
Priority to CA002142980A priority patent/CA2142980C/en
Publication of WO1994006492A1 publication Critical patent/WO1994006492A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16877Adjusting flow; Devices for setting a flow rate
    • A61M5/16881Regulating valves

Definitions

  • This invention relates to an implantable infusion system.
  • it relates to an improvement in an infusate accumulator used with a valve system in such a system operating at positive pressure to dispense medication in accordance with different specified flow rates.
  • a drug reservoir 10 is refillable by means of a septum 12.
  • the reservoir comprises a sealed housing 14 containing a bellows element 16 having a chamber 18 which comprises the drug reservoir.
  • the bellows 16 separates the housing 14 into a second zone 20 which is normally filled with a two-phase fluid.
  • the fluid normally Freon, vaporizes and compresses the bellows 16 thus providing a release pressure to the reservoir 18 through the outlet leading to the infusion site.
  • the two-phase fluid is then pressurized condensing a portion of the vapor and returning it to the liquid phase.
  • Such systems also employ an outlet filter 24 and a side port 27 for direct bolus injections.
  • the reservoir and fluid delivery techniques are well established in constant flow systems.
  • an accumulator 30 has been proposed for use in a number of applications.
  • a metering assembly comprising two normally closed valves 26 and 28. Interposed between the two valves is an accumulator 30.
  • the valves 26 and 28 are controlled electronically by the module 32 which may be programmed utilizing an external programmer 34.
  • valve 26 In operation of such a system, a constant positive pressure flow from the reservoir 10 to the inlet valve 26 occurs. Valve 26 is opened while the outlet valve 28 is closed. This loads the accumulator 30 with a predetermined amount of medication. The valve 26 is then closed and outlet valve 28 opened so that the contents of the accumulator 30 are delivered to the catheter 36 for delivery to the infusate site.
  • the rate of switching of the valves 26 and 28 thus determines the frequency of pumping through the system and therefore determines the delivery rate of medication through the catheter 36. For each cycle a constant amount equal to the accumulator volume is delivered.
  • the accumulator 30 has two alternative forms as illustrated in Figs. 2 and 3.
  • Figs. 2 and 3 utilize the same numbering as in the '887 patent.
  • the inlet is represented by numeral 58 wherein fluid enters the accumulator from the inlet valve 26.
  • the accumulator comprises a diaphragm 90, a backing plate 92, an end cap 94, a fill tube 96 and a spacer plate 98.
  • the diaphragm 90 deflects in response to fluid entry of the chamber 102.
  • the backing plate 92 acts as a mechanical stop to limit motion of the diaphragm.
  • the spacer plate 98 is used to limit diaphragm motion during discharge, that is, the passage of fluid through the outlet 59.
  • spacer plate 98 as a mechanical stop creates a problem when fragile materials such as insulin are used.
  • the material is locally compressed and crushed by the mechanical action of the diaphragm contacting the stop. This breaks down the fluid. Since the internal volumes are quite small, this in turn can result in residue formation inside the accumulator.
  • the fill tube 96 is used to supply an inert gas to the chamber 104.
  • the purpose of chamber 104 is to provide a region which is charged at a pressure lower than that of the infusate pressure in drug reservoir 18 so that accumulator chamber 102 fills when inlet valve 26 is opened, but higher in pressure than that of the catheter 36 to allow the diaphragm 90 to deflect back to the spacer plate 98 position as the chamber 102 empties when the outlet valve 28 is opened. Additional details of this accumulator may be found in U.S. Patent 4,838,887.
  • Figure 3 illustrates an alternative configuration.
  • the backing plate 92 comprises three elements which electrically isolate the center of the plate from the diaphragm 90.
  • a supply of inert gas is still supplied via the feed fill tube 96.
  • a lead 110 is attached to a flange forming a portion of the end cap assembly.
  • a ceramic cup 1 13, which is lined with metal 1 1 1 provides a conductive path between a stop 114 and the lead 110.
  • the diaphragm 90 is used as a moving switch contact. This provides a signal indicating that the accumulator is full, that is, the diaphragm in an upward position contacting the stop 114. This electrical signal is used for diagnostic determinations of the system such as leaks in the valve.
  • valve accumulator systems discussed herein function in a satisfactory manner and provide for an accurate metering of flow.
  • one difficulty common to all valve systems is damage to the fluid passing through it as a consequence of interaction with valves, diaphragms and the like.
  • various types of insulin are particularly sensitive to mechanically induced damage which tends to break down that material. This in turn causes a build-up of precipitate at the very location in the system, the accumulator, where metering accuracy is desired. Over time clogging can occur.
  • Yet another object of this invention is to provide an accumulator configuration having minimal size to thereby reduce the overall packaging of implantable medical devices.
  • a still further object of this invention is to provide an accumulator which does not utilize ' mechanical stops or spacer plate contact in the infusate path, thereby minimizing fluid contact points.
  • a spring biased pressure plate may be used or, as an alternative to the transfer fluid, a chamfered slider element may be used.
  • Fig. 1 is a schematic diagram illustrating a complete implantable system which employs an accumulator as described in U.S. Patent 4,838,887;
  • Fig. 2 is a schematic cut-away side view of an accumulator as described in U.S. Patent 4,838,887;
  • Fig. 3 is a schematic cut-away side view of a modified accumulator illustrated in U.S. Patent 4,838,887;
  • Fig. 4 is a schematic side view of an accumulator in accordance with the first preferred embodiment of this invention.
  • Fig. 5 is a schematic cut-away side view of an accumulator in accordance with a second preferred embodiment of this invention.
  • Fig. 6 is a schematic cut-away side view of an accumulator in accordance with a third preferred embodiment of this invention.
  • Fig. 7 is a schematic cut-away view of a fourth preferred embodiment of this invention. Description of the Invention
  • the accumulator of Fig. 4 also includes an intermediate member 45 with flow passages 45a and surface grooves 45b, which defines a transfer fluid chamber 46.
  • the presence of the surface grooves 45b is to allow the fluid to lift the diaphragm quicker thus decreasing the response time to fill from empty.
  • the transfer fluid chamber 46 is separated from the drug chamber 41 by means of a first diaphragm 47.
  • the transfer fluid chamber 46 is filled with transfer fluid 46a via a fill tube 48 which is sealed after the transfer fluid chamber 46 has been loaded.
  • the transfer fluid 46a may be any incompressible, low vapor pressure fluid such as silicone oil, water, or other material which can be used hydraulically to transfer the pressure difference which exists across first diaphragm 47 through flow passages 45a to a second diaphragm 52.
  • the second diaphragm 52 has a constant back pressure bias based on the pressure in cavity 50.
  • a backing plate 49 defines the cavity 50 which is filled with an inert gas such as Argon loaded to 4 psig, utilizing the fill tube 51 as illustrated.
  • This pressure can urge second diaphragm 52 downward, displacing the transfer fluid 46a in transfer fluid chamber 46 against first diaphragm 47, forcing a reduction in volume of drug chamber 41.
  • the first diaphragm 47 displaces as a function of the pressure difference between that which exists in the drug chamber 41 and in the transfer fluid chamber 46.
  • the input pressure in chamber 41 is greater than the pressure of transfer fluid 46a as biased by the gas in cavity 50.
  • first diaphragm 47 deflects upward which in turn causes second diaphragm 52 to deflect upward.
  • the volume in chamber 46 remains constant since the transfer fluid 46a is incompressible.
  • chamber 41 empties as first diaphragm 47 and second diaphragm 52 deflect downward.
  • first diaphragm 47 is not controlled by any mechanical stops. Instead, its motion is limited by the volume of transfer fluid 46a displaced in cavity 46 which in turn is limited by the displacement of second diaphragm 52.
  • the position of second diaphragm 52 is maintained by backing plate 49 and intermediate member 45.
  • FIG. 5 illustrates a second preferred embodiment of this invention.
  • like components are designated with the same numerals as in Fig. 4. To the extent that those items function in a similar manner, they will not be discussed with respect to this second preferred embodiment.
  • Figure 5 departs from Fig. 4 in several respects.
  • a substantially rigid spacer disc 60 having perforations is used in the transfer fluid chamber 46.
  • the perforated disc has a series of holes to allow fluid communication between upper and lower surfaces thereof.
  • the purpose of the disc 60 is to provide mechanical limit stops to both the first and second diaphragms 47 and 52, respectively.
  • the disc 60 has a surface texture characteristic such as micromachined flow channels or is roughened to provide a random flow pattern. Such is desired to decrease the response time of the system in a fashion similar to the use of surface grooves 45b of Fig. 4. That is, the valves need not be held in an open state longer than needed thus reducing battery power requirements.
  • a third preferred embodiment of this invention is depicted.
  • a chamfered slider 70 is used in place of the perforated disc 60 of the second preferred embodiment.
  • the slider 70 is positioned in a chamber 46' and it is located between diaphragms 47 and 52.
  • the slider 70 is a transfer medium functioning much like transfer fluid 46a.
  • Chamber 46' is like fluid chamber 46 and it can include transfer fluid 46a. in this embodiment, transfer fluid is not required in chamber 46' but it can be included, if desired.
  • the slider 70 employs contoured surfaces 72 and 74 on the upper and lower surfaces respectively. As illustrated in Fig.
  • FIG. 7 A fourth preferred embodiment is illustrated in Fig. 7.
  • the second diaphragm is in the form of an elastomeric diaphragm 80.
  • the elastomeric diaphragm 80 is clamped in place between the end cap 49 and a pressure spring adjustment member 82 which is threaded into place in a manner similar to that illustrated in Fig. 5.
  • a push pin 84 is spring biased by means of spring 86.
  • the position of the pressure spring adjustment member 82 sets the span between a head or end plate 85 of the push pin 84 and the upper flange 83 on adjustment member 82. This compresses the spring 86 which varies the back pressure on the pin and thus sets the position of the elastomeric diaphragm 80.
  • the head 85 of the push pin 84 is also limited in motion by the lower flange 87 on backing plate 49.
  • Figure 7 illustrates the use of a perforated screen 88. This is an optional element for purposes of safety to limit the upward deflection of the first diaphragm 47. It is however not required.
  • the transfer fluid 46a would be loaded into the transfer fluid chamber 46 or chamber 46' in a manner identical to that of Fig. 4. It is apparent from the description of the preferred embodiments herein that other modifications may be practiced without departing from the essential scope of this invention.
  • the spacer elements such as perforated disc 60, can be cantilevered elements and not a perforated disc.
  • a woven element or a porous plug could be substituted for perforated disc 60.
  • Absolute rigidity is required in any case so that the diaphragm is supported.
  • the slider 70 of Fig. 6 could be modified to include level sensing in the chamber 41 as a function of slider 70 position. This would be done by Hall effect, capacitive pick-up or metallic contact. By placing the sensor in the wall of intermediate member 45, the position of the slider 70 can be determined. The slider 70 would also be given a texture on surfaces contacting the first and second diaphragms 47 and 52, respectively, to increase flow-thru characteristics thus reducing power requirements.

Abstract

An accumulator (30) for an implantable infusion system employs a pair of separated diaphragms (47, 52) movable in unison by a transfer fluid disposed therebetween. An infusate chamber (41) receives infusate in metered amounts through inlet (42) and dispenses the contents as a function of a toggled valve operation. During filling, the first diaphragm (47) deflects upward and by pressure transfer causes a corresponding deflection in the second diaphragm (52). The second diaphragm (52) is biased by springs, gas under pressure or the like. Hence, when inlet valve (26) closes and outlet valve (28) opens, the pressure differential across second diaphragm (52) causes downward deflection and fluid flows through outlet (44). No mechanical stops are needed in chamber (41) for the first diaphragm (47) since its movement is controlled by the pressure differential across the second diaphragm (52).

Description

ACCUMULATOR FOR IMPLANTABLE PUMP
Background of the Invention This invention relates to an implantable infusion system. In particular, it relates to an improvement in an infusate accumulator used with a valve system in such a system operating at positive pressure to dispense medication in accordance with different specified flow rates.
Implantable infusion pumps utilizing an accumulator positioned between a pair of valves which alternately open and close are disclosed in U.S. Patents 4,838,887 and 5,049,141 , commonly assigned. The disclosure of the '887 patent is expressly incorporated herein by reference. In such a system, as illustrated in Fig. 1 , a drug reservoir 10 is refillable by means of a septum 12. The reservoir comprises a sealed housing 14 containing a bellows element 16 having a chamber 18 which comprises the drug reservoir. The bellows 16 separates the housing 14 into a second zone 20 which is normally filled with a two-phase fluid. The fluid, normally Freon, vaporizes and compresses the bellows 16 thus providing a release pressure to the reservoir 18 through the outlet leading to the infusion site. During the refill process chamber 18 is loaded with medication via the septum 12. The two-phase fluid is then pressurized condensing a portion of the vapor and returning it to the liquid phase.
Such systems also employ an outlet filter 24 and a side port 27 for direct bolus injections. The reservoir and fluid delivery techniques are well established in constant flow systems. To provide for increased accuracy in delivery dosage, the use of an accumulator 30 has been proposed for use in a number of applications.
These systems employ a metering assembly comprising two normally closed valves 26 and 28. Interposed between the two valves is an accumulator 30. The valves 26 and 28 are controlled electronically by the module 32 which may be programmed utilizing an external programmer 34.
In operation of such a system, a constant positive pressure flow from the reservoir 10 to the inlet valve 26 occurs. Valve 26 is opened while the outlet valve 28 is closed. This loads the accumulator 30 with a predetermined amount of medication. The valve 26 is then closed and outlet valve 28 opened so that the contents of the accumulator 30 are delivered to the catheter 36 for delivery to the infusate site. The rate of switching of the valves 26 and 28 thus determines the frequency of pumping through the system and therefore determines the delivery rate of medication through the catheter 36. For each cycle a constant amount equal to the accumulator volume is delivered.
In the system illustrated in Fig. 1 , the accumulator 30 has two alternative forms as illustrated in Figs. 2 and 3. For purposes of convenience, Figs. 2 and 3 utilize the same numbering as in the '887 patent. As illustrated in Fig. 2, the inlet is represented by numeral 58 wherein fluid enters the accumulator from the inlet valve 26. The accumulator comprises a diaphragm 90, a backing plate 92, an end cap 94, a fill tube 96 and a spacer plate 98. The diaphragm 90 deflects in response to fluid entry of the chamber 102. The backing plate 92 acts as a mechanical stop to limit motion of the diaphragm. Similarly, the spacer plate 98 is used to limit diaphragm motion during discharge, that is, the passage of fluid through the outlet 59.
The use of the spacer plate 98 as a mechanical stop creates a problem when fragile materials such as insulin are used. The material is locally compressed and crushed by the mechanical action of the diaphragm contacting the stop. This breaks down the fluid. Since the internal volumes are quite small, this in turn can result in residue formation inside the accumulator.
The fill tube 96 is used to supply an inert gas to the chamber 104. The purpose of chamber 104 is to provide a region which is charged at a pressure lower than that of the infusate pressure in drug reservoir 18 so that accumulator chamber 102 fills when inlet valve 26 is opened, but higher in pressure than that of the catheter 36 to allow the diaphragm 90 to deflect back to the spacer plate 98 position as the chamber 102 empties when the outlet valve 28 is opened. Additional details of this accumulator may be found in U.S. Patent 4,838,887.
Figure 3 illustrates an alternative configuration. In this alternative arrangement, the backing plate 92 comprises three elements which electrically isolate the center of the plate from the diaphragm 90. A supply of inert gas is still supplied via the feed fill tube 96. A lead 110 is attached to a flange forming a portion of the end cap assembly. A ceramic cup 1 13, which is lined with metal 1 1 1 , provides a conductive path between a stop 114 and the lead 110. The diaphragm 90 is used as a moving switch contact. This provides a signal indicating that the accumulator is full, that is, the diaphragm in an upward position contacting the stop 114. This electrical signal is used for diagnostic determinations of the system such as leaks in the valve. Again, more complete details as to the use of the modified accumulator of Fig. 3 are found in the '887 patent. A problem with these types of accumulators is the formation of precipitate on the spacer plate. Over time this build-up deteriorates the flow accuracy in the system and in an extreme case causes blockage. U.S. Patent 5,049,141 addresses this problem by minimizing the contact points with the diaphragm. This solution reduces stress points on the fluid within the accumulator. There are however still points of contact and therefore potential damage to the material.
Summary of the Invention
The valve accumulator systems discussed herein function in a satisfactory manner and provide for an accurate metering of flow. However, one difficulty common to all valve systems is damage to the fluid passing through it as a consequence of interaction with valves, diaphragms and the like. In particular, various types of insulin are particularly sensitive to mechanically induced damage which tends to break down that material. This in turn causes a build-up of precipitate at the very location in the system, the accumulator, where metering accuracy is desired. Over time clogging can occur.
Therefore, it is an object of this invention to provide an improved accumulator which minimizes damage to sensitive materials passing through an implantable pump system.
Yet another object of this invention is to provide an accumulator configuration having minimal size to thereby reduce the overall packaging of implantable medical devices.
A still further object of this invention is to provide an accumulator which does not utilize 'mechanical stops or spacer plate contact in the infusate path, thereby minimizing fluid contact points. These and other objects of this invention are accomplished by means of a dual diaphragm accumulator configuration. The first diaphragm performs the steps of fluid transfer as in prior art systems. The second diaphragm is separated from the first by means of a transfer fluid. The first diaphragm has no mechanical stops associated with it but deflects as a function of the difference in pressure between the drug chamber and the transfer fluid chamber. The second diaphragm deflects between positions and has mechanical stops. It is biased by gas, springs and the like to provide a restoring bias hydraulically to the system, i.e., to cause the first diaphragm to store or expel fluid. As an alternative to the gas, a spring biased pressure plate may be used or, as an alternative to the transfer fluid, a chamfered slider element may be used.
This invention will be described in greater detail by referring to the drawing and the description of the preferred embodiment which follows. Brief Description of the Drawings
Fig. 1 is a schematic diagram illustrating a complete implantable system which employs an accumulator as described in U.S. Patent 4,838,887;
Fig. 2 is a schematic cut-away side view of an accumulator as described in U.S. Patent 4,838,887; Fig. 3 is a schematic cut-away side view of a modified accumulator illustrated in U.S. Patent 4,838,887;
Fig. 4 is a schematic side view of an accumulator in accordance with the first preferred embodiment of this invention;
Fig. 5 is a schematic cut-away side view of an accumulator in accordance with a second preferred embodiment of this invention;
Fig. 6 is a schematic cut-away side view of an accumulator in accordance with a third preferred embodiment of this invention; and
Fig. 7 is a schematic cut-away view of a fourth preferred embodiment of this invention. Description of the Invention
Referring now to Fig. 4, a first preferred embodiment of this invention is depicted. A drug chamber 41 receives fluid via the inlet 42. It will be understood that the inlet 42 is coupled to an inlet valve, such as element 26 depicted in Fig. 1. The inlet pressure is approximately 8.5 psig. The inlet 42 is formed in the spacer plate 43 which also has an outlet 44 from the drug chamber 41 of the accumulator.
The accumulator of Fig. 4 also includes an intermediate member 45 with flow passages 45a and surface grooves 45b, which defines a transfer fluid chamber 46. The presence of the surface grooves 45b is to allow the fluid to lift the diaphragm quicker thus decreasing the response time to fill from empty. The transfer fluid chamber 46 is separated from the drug chamber 41 by means of a first diaphragm 47. The transfer fluid chamber 46 is filled with transfer fluid 46a via a fill tube 48 which is sealed after the transfer fluid chamber 46 has been loaded. The transfer fluid 46a may be any incompressible, low vapor pressure fluid such as silicone oil, water, or other material which can be used hydraulically to transfer the pressure difference which exists across first diaphragm 47 through flow passages 45a to a second diaphragm 52. The second diaphragm 52 has a constant back pressure bias based on the pressure in cavity 50. A backing plate 49 defines the cavity 50 which is filled with an inert gas such as Argon loaded to 4 psig, utilizing the fill tube 51 as illustrated. This pressure can urge second diaphragm 52 downward, displacing the transfer fluid 46a in transfer fluid chamber 46 against first diaphragm 47, forcing a reduction in volume of drug chamber 41. In operation, the first diaphragm 47 displaces as a function of the pressure difference between that which exists in the drug chamber 41 and in the transfer fluid chamber 46. During filling, the input pressure in chamber 41 is greater than the pressure of transfer fluid 46a as biased by the gas in cavity 50. Therefore, the first diaphragm 47 deflects upward which in turn causes second diaphragm 52 to deflect upward. The volume in chamber 46 remains constant since the transfer fluid 46a is incompressible. Similarly, when valve 28 is opened chamber 41 empties as first diaphragm 47 and second diaphragm 52 deflect downward.
However, the motion of first diaphragm 47 is not controlled by any mechanical stops. Instead, its motion is limited by the volume of transfer fluid 46a displaced in cavity 46 which in turn is limited by the displacement of second diaphragm 52. The position of second diaphragm 52 is maintained by backing plate 49 and intermediate member 45. These elements perform the same function as backing plate 92 and spacer plate 98 in Fig. 2, respectively.
By eliminating mechanical stops, fluid stresses generated in the drug chamber 41 by contact points against accumulator first diaphragm 47 are eliminated. These stresses would tend to produce protein precipitation in the drug chamber 41 , hindering accumulator performance. The use of the dual diaphragm accumulator eliminates the need for contact with the spacer plate 98 of Fig. 2 and thus eliminates the problem of damage to the fluid passing therethrough. It will again be appreciated from the description of this first preferred embodiment that the second diaphragm 52 is in direct fluid communication with the first diaphragm 47 via the transfer fluid 46a in second chamber 46 through flow passages 45a. Consequently, the volume displaced by second diaphragm 52 as it travels between backing plate 49 and intermediate member 45 is the identical volume displaced by first diaphragm 47 as it is urged up and down via the transfer fluid 46a in transfer fluid chamber 46.
Figure 5 illustrates a second preferred embodiment of this invention. In Fig. 5 like components are designated with the same numerals as in Fig. 4. To the extent that those items function in a similar manner, they will not be discussed with respect to this second preferred embodiment.
Figure 5 departs from Fig. 4 in several respects. First, a substantially rigid spacer disc 60 having perforations is used in the transfer fluid chamber 46. The perforated disc has a series of holes to allow fluid communication between upper and lower surfaces thereof. The purpose of the disc 60 is to provide mechanical limit stops to both the first and second diaphragms 47 and 52, respectively.
Secondly, Fig. 5 does not utilize a gas back pressure chamber. Rather, a pressure plate 62 provides the necessary bias to second diaphragm 52. Pressure adjustment is accomplished by providing a section of the inner wall of member 49 with a threaded element. A compatible threaded back plate 66 is provided with a spring 68. By threading the plate 66 using threads 64, the spring tension is adjusted thereby providing variable pressure onto the pressure plate 62.
This embodiment therefore eliminates the second pressurized cavity 50. It is apparent however that the perforated disc 60 could be used in conjunction with the embodiment of Fig. 4 while still retaining the back pressure provided by the cavity 50.
The disc 60 has a surface texture characteristic such as micromachined flow channels or is roughened to provide a random flow pattern. Such is desired to decrease the response time of the system in a fashion similar to the use of surface grooves 45b of Fig. 4. That is, the valves need not be held in an open state longer than needed thus reducing battery power requirements.
Referring now to Fig. 6, a third preferred embodiment of this invention is depicted. In the third embodiment Fig. 6, in place of the perforated disc 60 of the second preferred embodiment, a chamfered slider 70 is used. The slider 70 is positioned in a chamber 46' and it is located between diaphragms 47 and 52. The slider 70 is a transfer medium functioning much like transfer fluid 46a. Chamber 46' is like fluid chamber 46 and it can include transfer fluid 46a. in this embodiment, transfer fluid is not required in chamber 46' but it can be included, if desired. The slider 70 employs contoured surfaces 72 and 74 on the upper and lower surfaces respectively. As illustrated in Fig. 6, when the slider 70 is biased upward, that is, with the chamber 41 filled, it displaces second diaphragm 52 as illustrated. Conversely, as the chamber 41 empties the slider 70 is lowered given the pressure differential across the second diaphragm 52. The slider 70 rests on the lower shoulder 77 of the spacer plate 43. This acts as a limit stop for the slider 70 and thus, first diaphragm 47 will no longer deflect. However, the stop is defined between the side of the first diaphragm 47 and lower shoulder 77 not in fluid contact with the infusate in chamber 41. Thus, that material cannot be damaged during passage through the accumulator. Similarly, an upper shoulder 78 on backing plate 49 acts as a limit stop for the slider 70 to control the upward motion of first diaphragm 47. It should be noted that upper shoulder 78 and/or lower shoulder 77 could also be located on intermediate member 45.
A fourth preferred embodiment is illustrated in Fig. 7. In this embodiment, the second diaphragm is in the form of an elastomeric diaphragm 80. The elastomeric diaphragm 80 is clamped in place between the end cap 49 and a pressure spring adjustment member 82 which is threaded into place in a manner similar to that illustrated in Fig. 5. A push pin 84 is spring biased by means of spring 86.
As illustrated in Fig. 7, the position of the pressure spring adjustment member 82 sets the span between a head or end plate 85 of the push pin 84 and the upper flange 83 on adjustment member 82. This compresses the spring 86 which varies the back pressure on the pin and thus sets the position of the elastomeric diaphragm 80. The head 85 of the push pin 84 is also limited in motion by the lower flange 87 on backing plate 49.
Figure 7 illustrates the use of a perforated screen 88. This is an optional element for purposes of safety to limit the upward deflection of the first diaphragm 47. It is however not required.
While not illustrated in Figs 6 and 7, it is apparent that the transfer fluid 46a would be loaded into the transfer fluid chamber 46 or chamber 46' in a manner identical to that of Fig. 4. It is apparent from the description of the preferred embodiments herein that other modifications may be practiced without departing from the essential scope of this invention. For example, the spacer elements, such as perforated disc 60, can be cantilevered elements and not a perforated disc. Also, a woven element or a porous plug could be substituted for perforated disc 60. Absolute rigidity is required in any case so that the diaphragm is supported.
The slider 70 of Fig. 6 could be modified to include level sensing in the chamber 41 as a function of slider 70 position. This would be done by Hall effect, capacitive pick-up or metallic contact. By placing the sensor in the wall of intermediate member 45, the position of the slider 70 can be determined. The slider 70 would also be given a texture on surfaces contacting the first and second diaphragms 47 and 52, respectively, to increase flow-thru characteristics thus reducing power requirements.

Claims

1. An accumulator (30) for an implantable pump infusion system comprising a housing having an infusate chamber (41), a first diaphragm (47), a second chamber (46) containing a transfer medium and separated from said first chamber by said first diaphragm, characterized by a second diaphragm (52) in said housing in contact with said transfer medium and means to bias said second diaphragm for deflection toward said first diaphragm.
2. The accumulator of claim 1 , wherein said means to bias said second diaphragm comprises a sealed gas chamber (50) charged with a fluid under pressure.
3. The accumulator of claim 1 further comprising contact means apart from said infusate chamber to limit deflection of at least two surfaces of said first and second diaphragms.
4. The accumulator of claim 3, wherein said contact means comprises a movable member (70) in said second chamber.
5. The accumulator of claim 3, wherein said contact means comprises a rigid member (60) in said second chamber.
6. The accumulator of claim 1 , wherein said means to bias said second diaphragm comprises a pressure plate (62) in contact with said second diaphragm and spring means to apply a bias force to said pressure plate.
7. The accumulator of claim 6, wherein said spring means comprises a member (66) threaded in said housing, a spring (68) coupled to said pressure plate and to said threaded member whereby said spring is compressed as said threaded member is threaded into said housing.
8. The accumulator of claim 7, wherein said pressure plate comprises a pin (84) having an end plate (85) attached thereto, said spring placed around said pin and means to determine the position of said pin.
9. The accumulator of claim 3, wherein said contact means comprises a perforated member (88) in said second chamber.
10. The accumulator of claim 1 , wherein said transfer medium is an incompressible fluid (46a) and said accumulator further comprises means to fill said second chamber with said incompressible fluid.
1 1 . The accumulator of claim 1 , wherein said transfer medium is a chamfered slider (70).
12. The accumulator of claim 4 wherein said movable member has sides contacting internal shoulders (77)(78) in said housing to limit movement of said movable member.
13. The accumulator of claim 12 further comprising means to determine the position of said movable member.
14. The accumulator of claim 3, wherein said contact means has surface characteristics (45b) on major surfaces thereof to promote flow between said major surfaces and said diaphragm surfaces.
PCT/US1993/006775 1992-09-18 1993-07-22 Accumulator for implantable pump WO1994006492A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE69308578T DE69308578T2 (en) 1992-09-18 1993-07-22 MEMORY FOR IMPLANTABLE PUMP
DE9390324U DE9390324U1 (en) 1992-09-18 1993-07-22 Pressure accumulator for implantable pumps
AU46840/93A AU674332B2 (en) 1992-09-18 1993-07-22 Accumulator for implantable pump
EP93917277A EP0660728B1 (en) 1992-09-18 1993-07-22 Accumulator for implantable pump
CA002142980A CA2142980C (en) 1992-09-18 1993-07-22 Accumulator for implantable pump

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/946,848 1992-09-18
US07/946,848 US5281210A (en) 1992-09-18 1992-09-18 Accumulator for implantable pump

Publications (1)

Publication Number Publication Date
WO1994006492A1 true WO1994006492A1 (en) 1994-03-31

Family

ID=25485062

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/006775 WO1994006492A1 (en) 1992-09-18 1993-07-22 Accumulator for implantable pump

Country Status (9)

Country Link
US (1) US5281210A (en)
EP (1) EP0660728B1 (en)
JP (1) JP2744136B2 (en)
AT (1) ATE149356T1 (en)
AU (1) AU674332B2 (en)
CA (1) CA2142980C (en)
DE (2) DE9390324U1 (en)
ES (1) ES2099461T3 (en)
WO (1) WO1994006492A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2151407A1 (en) * 1995-06-09 1996-12-10 Duncan Newman Injection device
US6270326B1 (en) 1997-08-29 2001-08-07 Seiko Epson Corporation Transfusion device and liquid supply tube
US6203523B1 (en) * 1998-02-02 2001-03-20 Medtronic Inc Implantable drug infusion device having a flow regulator
US6048328A (en) * 1998-02-02 2000-04-11 Medtronic, Inc. Implantable drug infusion device having an improved valve
US6090062A (en) * 1998-05-29 2000-07-18 Wayne State University Programmable antisiphon shunt system
EP1356837A1 (en) * 1998-06-18 2003-10-29 Medical Research Group, Inc. Medical infusion device with a source of controlled compliance
WO1999065540A2 (en) * 1998-06-18 1999-12-23 Medical Research Group, Inc. Medical infusion device with a source of controlled compliance
US6471675B1 (en) * 1999-04-30 2002-10-29 Medtronic, Inc. Passive flow control devices for implantable pumps
US6635049B1 (en) * 1999-04-30 2003-10-21 Medtronic, Inc. Drug bolus delivery system
US6471689B1 (en) * 1999-08-16 2002-10-29 Thomas Jefferson University Implantable drug delivery catheter system with capillary interface
US6764472B1 (en) * 2000-01-11 2004-07-20 Bard Access Systems, Inc. Implantable refillable infusion device
US20040073175A1 (en) * 2002-01-07 2004-04-15 Jacobson James D. Infusion system
JP4565193B2 (en) 2003-04-23 2010-10-20 バレリタス, インコーポレイテッド Hydraulically operated pump for long duration pharmaceutical administration
EP1635894B1 (en) * 2003-06-25 2015-05-27 Infusion Systems, LLC Medication infusion device using negatively biased ambient pressure medication chamber
US9089636B2 (en) 2004-07-02 2015-07-28 Valeritas, Inc. Methods and devices for delivering GLP-1 and uses thereof
US20060116648A1 (en) * 2004-07-26 2006-06-01 Bret Hamatake Port design and method of assembly
US8100889B2 (en) * 2004-11-10 2012-01-24 Olympus Corporation Body-insertable apparatus
EP2005309B1 (en) 2006-03-30 2016-02-17 Valeritas, Inc. Multi-cartridge fluid delivery device
US8251960B2 (en) 2007-03-24 2012-08-28 The Alfred E. Mann Foundation For Scientific Research Valves, valved fluid transfer devices and ambulatory infusion devices including the same
US8740861B2 (en) 2007-03-24 2014-06-03 Medallion Therapeutics, Inc. Valves, valved fluid transfer devices and ambulatory infusion devices including the same
US20080234639A1 (en) * 2007-03-24 2008-09-25 David Christopher Antonio Valves, Valved Fluid Transfer Devices and Ambulatory Infusion Devices Including The Same
US8273058B2 (en) 2007-10-04 2012-09-25 Flowonix Medical Incorporated Two way accumulator programmable valve pump
US8551044B2 (en) * 2008-03-05 2013-10-08 Flowonix Medical Incorporated Multiple reservoir implantable drug infusion device and method
US20100042213A1 (en) * 2008-08-13 2010-02-18 Nebosky Paul S Drug delivery implants
WO2010019807A1 (en) * 2008-08-13 2010-02-18 Smed-Ta/Td, Llc Orthopaedic implant with spatially varying porosity
US10842645B2 (en) 2008-08-13 2020-11-24 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
US9700431B2 (en) 2008-08-13 2017-07-11 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
JP5774989B2 (en) * 2008-08-13 2015-09-09 スメド−ティーエイ/ティーディー・エルエルシー Orthopedic screw
US9616205B2 (en) 2008-08-13 2017-04-11 Smed-Ta/Td, Llc Drug delivery implants
EP2341852B1 (en) * 2008-08-29 2018-08-15 SMed-TA/TD, LLC Orthopaedic implant
US20110166522A1 (en) * 2010-01-06 2011-07-07 Medtronic, Inc. Accumulator for therapeutic fluid delivery devices
US8545484B2 (en) 2011-10-18 2013-10-01 Medtronic, Inc. Accumulator for implantable infusion device
KR102250698B1 (en) * 2019-05-13 2021-05-12 주식회사 필로시스 Method and device to inject medicine
US11745003B2 (en) 2020-10-30 2023-09-05 Medtronic, Inc. Implantable access port with one-directional filter
US11931545B2 (en) 2020-10-30 2024-03-19 Medtronic, Inc. Drug infusion port

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2354106A1 (en) * 1976-06-11 1978-01-06 Siemens Ag NEW DOSER THAT CAN BE IMPLANTED
FR2370184A1 (en) * 1976-11-09 1978-06-02 Nikkiso Co Ltd PULSATORY PUMP FOR BLOOD CIRCULATION
US4443218A (en) * 1982-09-09 1984-04-17 Infusaid Corporation Programmable implantable infusate pump
US4714462A (en) * 1986-02-03 1987-12-22 Intermedics Infusaid, Inc. Positive pressure programmable infusion pump
DE3634725A1 (en) * 1986-10-11 1988-04-14 Holzer Walter Dosing pump, e.g. for insulin
EP0410125A1 (en) * 1989-07-27 1991-01-30 Tetra Dev-Co Piston unit with rolling membrane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299220A (en) * 1979-05-03 1981-11-10 The Regents Of The University Of Minnesota Implantable drug infusion regulator
US4668231A (en) * 1984-02-15 1987-05-26 Cordis Corporation Implantable hand-operable dispensers for fluid medicaments
DE3577039D1 (en) * 1984-06-21 1990-05-17 David R Fischell FINGER-ACTUATED INFUSION SYSTEM FOR THE MEDICAL SUPPLY.
US4838887A (en) * 1987-12-15 1989-06-13 Shiley Infusaid Inc. Programmable valve pump
US4820273A (en) * 1988-03-01 1989-04-11 Eaton Corporation Implantable medication infusion device and bolus generator therefor
US5053031A (en) * 1988-03-29 1991-10-01 Baxter International Inc. Pump infusion system
AT391416B (en) * 1988-06-23 1990-10-10 Annemarie Schloegl Ges M B H M SEPTUM FOR IMPLANTABLE DEVICES FOR DELIVERING ACTIVE SUBSTANCES
US5137529A (en) * 1990-02-20 1992-08-11 Pudenz-Schulte Medical Research Corporation Injection port
US5049141A (en) * 1990-04-25 1991-09-17 Infusaid, Inc. Programmable valve pump
US5090963A (en) * 1990-10-19 1992-02-25 Product Development (Z.G.S.) Ltd. Electrochemically driven metering medicament dispenser

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2354106A1 (en) * 1976-06-11 1978-01-06 Siemens Ag NEW DOSER THAT CAN BE IMPLANTED
FR2370184A1 (en) * 1976-11-09 1978-06-02 Nikkiso Co Ltd PULSATORY PUMP FOR BLOOD CIRCULATION
US4443218A (en) * 1982-09-09 1984-04-17 Infusaid Corporation Programmable implantable infusate pump
US4714462A (en) * 1986-02-03 1987-12-22 Intermedics Infusaid, Inc. Positive pressure programmable infusion pump
DE3634725A1 (en) * 1986-10-11 1988-04-14 Holzer Walter Dosing pump, e.g. for insulin
EP0410125A1 (en) * 1989-07-27 1991-01-30 Tetra Dev-Co Piston unit with rolling membrane

Also Published As

Publication number Publication date
AU674332B2 (en) 1996-12-19
DE69308578D1 (en) 1997-04-10
AU4684093A (en) 1994-04-12
US5281210A (en) 1994-01-25
ATE149356T1 (en) 1997-03-15
ES2099461T3 (en) 1997-05-16
EP0660728B1 (en) 1997-03-05
DE69308578T2 (en) 1997-06-12
JP2744136B2 (en) 1998-04-28
DE9390324U1 (en) 1995-09-14
CA2142980C (en) 1999-10-05
CA2142980A1 (en) 1994-03-31
EP0660728A1 (en) 1995-07-05
JPH07509168A (en) 1995-10-12

Similar Documents

Publication Publication Date Title
US5281210A (en) Accumulator for implantable pump
KR0139651B1 (en) Programmable valve pump
EP0387439B1 (en) Implantable infusion device
US4221219A (en) Implantable infusion apparatus and method
US4715852A (en) Implanted medication infusion device
EP0488701B1 (en) Liquid-vapour pressure reservoir for medication infusion pump
US5725017A (en) In-line pressure check valve for drug-delivery systems
US4714462A (en) Positive pressure programmable infusion pump
US4944659A (en) Implantable piezoelectric pump system
US5759015A (en) Piezoelectric micropump having actuation electrodes and stopper members
US4447224A (en) Variable flow implantable infusion apparatus
US8696627B2 (en) Two way accumulator programmable valve pump
WO1997007840A1 (en) Implantable drug delivery apparatus
CA1307178C (en) Programmable valve pump
WO2021119101A1 (en) Flowrate control for self-pressurized reservoir of a device for delivering medication
WO2006037330A1 (en) A pumping system and a method for controlling a fluid flow in a pumping system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA DE JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2142980

Country of ref document: CA

Ref document number: 1993917277

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT.BUL.08/94 UNDER INID (81) "DESIGNATED STATES",INSERT "(UTILITY MODEL)" AFTER "DE"

WWP Wipo information: published in national office

Ref document number: 1993917277

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1993917277

Country of ref document: EP